[go: up one dir, main page]

FI960095L - Menetelmä atsetidinonien syntetitoimiseksi - Google Patents

Menetelmä atsetidinonien syntetitoimiseksi Download PDF

Info

Publication number
FI960095L
FI960095L FI960095A FI960095A FI960095L FI 960095 L FI960095 L FI 960095L FI 960095 A FI960095 A FI 960095A FI 960095 A FI960095 A FI 960095A FI 960095 L FI960095 L FI 960095L
Authority
FI
Finland
Prior art keywords
azetidinones
synthesizing
synthesizing azetidinones
Prior art date
Application number
FI960095A
Other languages
English (en)
Swedish (sv)
Other versions
FI960095A7 (fi
FI960095A0 (fi
Inventor
Tiruvettipuram K Thiruvengadam
Timothy Mcallister
Chou-Hong Tann
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22217215&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI960095(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI960095A7 publication Critical patent/FI960095A7/fi
Publication of FI960095A0 publication Critical patent/FI960095A0/fi
Publication of FI960095L publication Critical patent/FI960095L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
FI960095A 1993-07-09 1994-07-01 Menetelmä atsetidinonien syntetitoimiseksi FI960095L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8935793A 1993-07-09 1993-07-09
PCT/US1994/007291 WO1995001961A1 (en) 1993-07-09 1994-07-01 Process for the synthesis of azetidinones

Publications (3)

Publication Number Publication Date
FI960095A7 FI960095A7 (fi) 1996-01-09
FI960095A0 FI960095A0 (fi) 1996-01-09
FI960095L true FI960095L (fi) 1996-01-09

Family

ID=22217215

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960095A FI960095L (fi) 1993-07-09 1994-07-01 Menetelmä atsetidinonien syntetitoimiseksi

Country Status (21)

Country Link
US (1) US5728827A (fi)
EP (1) EP0707567B1 (fi)
JP (1) JP2840452B2 (fi)
KR (1) KR0176001B1 (fi)
CN (1) CN1071745C (fi)
AT (1) ATE205475T1 (fi)
AU (1) AU681419B2 (fi)
CA (1) CA2166784C (fi)
CZ (1) CZ7696A3 (fi)
DE (1) DE69428280T2 (fi)
DK (1) DK0707567T3 (fi)
ES (1) ES2160125T3 (fi)
FI (1) FI960095L (fi)
HU (1) HUT73237A (fi)
MX (1) MX9405152A (fi)
NO (1) NO306294B1 (fi)
NZ (1) NZ268798A (fi)
PL (1) PL312502A1 (fi)
PT (1) PT707567E (fi)
SK (1) SK3796A3 (fi)
WO (1) WO1995001961A1 (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
ES2244238T3 (es) * 1998-12-07 2005-12-01 Schering Corporation Proceso para la sintesis de azetidinonas.
US6207822B1 (en) 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
WO2000063703A1 (en) 1999-04-16 2000-10-26 Schering Corporation Use of azetidinone compounds
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
IL156445A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
SI1355644T1 (sl) 2001-01-26 2006-10-31 Schering Corp Uporaba substituiranih azetidinonskih spojin za zdravljenje sitosterolemije
RS50386B (sr) 2001-03-28 2009-12-31 Schering Corporation, Enantioselektivna sinteza intermedijarnih jedinjenja azetidinona
DK1429756T3 (da) 2001-09-21 2007-03-19 Schering Corp Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030204096A1 (en) * 2002-03-25 2003-10-30 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) * 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
US20040092499A1 (en) 2002-11-06 2004-05-13 Schering Corporation Methods and therapeutic combinations for the treatment of autoimmune disorders
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
ATE418551T1 (de) * 2003-03-07 2009-01-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2005061452A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
CN100471835C (zh) * 2003-12-23 2009-03-25 默克公司 抗高胆固醇血症化合物
EP1723414A4 (en) * 2004-01-16 2008-03-26 Merck & Co Inc Npc1l1 (npc3) and methods of identifying ligands thereof
DE102004025071B4 (de) * 2004-05-21 2006-12-21 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
BRPI0510150A (pt) 2004-05-21 2007-10-02 Sanofi Aventis Deutschland processo para preparação de derivados de 1,4-difenilacetidinonas
CA2591564A1 (en) * 2004-12-20 2006-06-29 Schering Corporation Process for the synthesis of azetidinones
EP1902046B1 (en) * 2005-06-20 2009-12-02 Schering Corporation Piperidine derivatives useful as histamine h3 antagonists
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
WO2007100807A2 (en) * 2006-02-24 2007-09-07 Schering Corporation Npc1l1 orthologues
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
MX2009002398A (es) * 2006-09-05 2009-03-16 Schering Corp Combinaciones farmaceuticas para manejo de lipidos y en el tratamiento de aterosclerosis y estatosis hepatica.
WO2008032338A2 (en) * 2006-09-11 2008-03-20 Manne Satyanarayana Reddy Improved process for the preparation of ezetimibe and its intermediates
CN101679236B (zh) 2007-01-24 2013-03-06 克尔克公司 依泽替米贝的制备方法和其的衍生物
WO2010113175A2 (en) 2009-04-01 2010-10-07 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN104803858B (zh) * 2014-01-23 2019-03-01 东莞东阳光科研发有限公司 一种制备四丁基氟化铵三水合物的方法
WO2021155841A1 (en) 2020-02-07 2021-08-12 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
WO2024169952A1 (en) 2023-02-16 2024-08-22 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333268A1 (en) * 1988-03-18 1989-09-20 Merck & Co. Inc. Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
US4876365A (en) * 1988-12-05 1989-10-24 Schering Corporation Intermediate compounds for preparing penems and carbapenems
US4983597A (en) * 1989-08-31 1991-01-08 Merck & Co., Inc. Beta-lactams as anticholesterolemic agents
US5085473A (en) * 1990-10-09 1992-02-04 Yuhe Yang Air actuated car curtain device
DE69222532T2 (de) * 1991-07-23 1998-02-26 Schering Corp Substituierte beta-lactam-verbindungen als hypocholesterolemische mittel und verfahren zu deren herstellung

Also Published As

Publication number Publication date
PT707567E (pt) 2002-01-30
SK3796A3 (en) 1997-02-05
WO1995001961A1 (en) 1995-01-19
FI960095A7 (fi) 1996-01-09
NO960083L (no) 1996-03-04
NO960083D0 (no) 1996-01-08
US5728827A (en) 1998-03-17
MX9405152A (es) 1995-01-31
CZ7696A3 (en) 1996-04-17
AU7214694A (en) 1995-02-06
CA2166784A1 (en) 1995-01-19
EP0707567A1 (en) 1996-04-24
ES2160125T3 (es) 2001-11-01
HU9503748D0 (en) 1996-02-28
KR960703853A (ko) 1996-08-31
CN1126989A (zh) 1996-07-17
FI960095A0 (fi) 1996-01-09
JP2840452B2 (ja) 1998-12-24
DE69428280D1 (de) 2001-10-18
AU681419B2 (en) 1997-08-28
NO306294B1 (no) 1999-10-18
DE69428280T2 (de) 2002-06-13
JPH08507085A (ja) 1996-07-30
CN1071745C (zh) 2001-09-26
ATE205475T1 (de) 2001-09-15
EP0707567B1 (en) 2001-09-12
DK0707567T3 (da) 2001-11-26
NZ268798A (en) 1997-01-29
HUT73237A (en) 1996-07-29
PL312502A1 (en) 1996-04-29
KR0176001B1 (ko) 1999-03-20
CA2166784C (en) 2001-12-11

Similar Documents

Publication Publication Date Title
FI960095L (fi) Menetelmä atsetidinonien syntetitoimiseksi
FI960173L (fi) Menetelmä sakkaridikoostumusten syntetisoimiseksi
FI970102L (fi) Menetelmä substiuoitujen sulfoksidien syntetisoimiseksi
FI955132A7 (fi) Menetelmä sementin tuottamiseksi
DE69617372D1 (de) Datenaufzeichnungs-/-wiedergabeverfahren
FI956135A0 (fi) Erotusmenetelmä
FI944226A0 (fi) Menetelmä tietovirtojen yhdistämiseksi
FI943870A7 (fi) Menetelmä selluloosan käsittelemiseksi
FI944619A7 (fi) Aldolisointi-dehydratointimenetelmä
DE69432015D1 (de) Verfahren
DE69414001D1 (de) Bestimmungsmethode
FI954423L (fi) Menetelmä taksoidien puhdistamiseksi
FI961431L (fi) Prosessi II
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
DE69520558D1 (de) Halogenierungsverfahren
FI953993L (fi) Menetelmä betonin valmistamiseksi
FI931850L (fi) Menetelmä välituotteen valmistamiseksi
DE69425480D1 (de) Dokumentaufbereitungsapparat
DE69507032D1 (de) Chlorhydrin-verfahren
DK96392D0 (da) Modifikationsmetode
BR9408521A (pt) Método para sintetizar gama-pironas
EE9400450A (et) Meetod detailide töötlemiseks
KR970006291A (ko) 치환된 아미노카보닐트리아졸리논의 제조방법
FI974377A7 (fi) Pistemuokkausjärjestelmä
FI931051A7 (fi) Kuvausmenetelmä